Wang Yan, Yao Rongrong, Zhang Danying, Chen Rongxin, Ren Zhenggang, Zhang Lan
Department of Hepatic Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Department of Oncology, Huashan Hospital, Fudan University, Shanghai 201907, P.R.China.
J Cancer. 2020 Apr 6;11(13):3736-3744. doi: 10.7150/jca.42953. eCollection 2020.
: Tumor-associated neutrophils (TANs) contribute to tumor progression, invasion, and angiogenesis. However, most studies focus on tumor infiltration neutrophils while the roles of circulating neutrophils in tumor progression remain unclear. This study was aimed to verify the pro-tumor effects of circulating neutrophils and its' mechanism in HCC. : We collected clinical data of 127 HCC patients underwent TACE. The prognostic factors for overall survival (OS) were analyzed by Kaplan-Meier curve and Cox models. Circulating neutrophils of HCC patients were sorted and co-cultured with human HCC cell lines MHCC-97H and SMMC-7721. Then we detected tumor cells' proliferation, migration, and invasion. Phosphokinase array was used to determine the kinase profile on MHCC-97H and SMMC-7721 cultured with or without circulating neutrophils. : The result of multivariate analyses of 127 patients showed that increased circulating neutrophils was an independent poor prognostic factor for OS of HCC patients underwent TACE. Circulating neutrophils promoted migration and invasion of HCC cell lines but had no impact on proliferation. The kinase profile on HCC cell lines showed that p-p53 and p-STAT3 were up-regulated after co-cultured with circulating neutrophils. Repeated scratch tests and transwell tests showed a reversed impact on migration and invasion of circulating neutrophils after we treated HCC cell lines with inhibitors of p53 or STAT3. : Circulating neutrophils was an independent poor prognostic factor for OS of HCC patients underwent TACE. It had pro-tumor effect on HCC through p53 and STAT3 signaling pathway.
肿瘤相关中性粒细胞(TANs)促进肿瘤进展、侵袭和血管生成。然而,大多数研究集中于肿瘤浸润性中性粒细胞,而循环中性粒细胞在肿瘤进展中的作用仍不清楚。本研究旨在验证循环中性粒细胞在肝癌中的促肿瘤作用及其机制。
我们收集了127例行肝动脉化疗栓塞术(TACE)的肝癌患者的临床资料。通过Kaplan-Meier曲线和Cox模型分析总生存(OS)的预后因素。对肝癌患者的循环中性粒细胞进行分选,并与人肝癌细胞系MHCC-97H和SMMC-7721共培养。然后我们检测肿瘤细胞的增殖、迁移和侵袭。使用磷酸激酶阵列确定在有或无循环中性粒细胞培养条件下MHCC-97H和SMMC-7721上的激酶谱。
127例患者的多因素分析结果显示,循环中性粒细胞增多是行TACE的肝癌患者OS的独立不良预后因素。循环中性粒细胞促进肝癌细胞系的迁移和侵袭,但对增殖无影响。肝癌细胞系上的激酶谱显示,与循环中性粒细胞共培养后,p-p53和p-STAT3上调。在用p53或STAT3抑制剂处理肝癌细胞系后,重复划痕试验和Transwell试验显示对循环中性粒细胞的迁移和侵袭有相反的影响。
循环中性粒细胞是行TACE的肝癌患者OS的独立不良预后因素。它通过p53和STAT3信号通路对肝癌具有促肿瘤作用。